Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

Global Enteral Nutrition Market, By Product Type (Standard Enteral Nutrition and Enteral Nutrition for Chronic Illness), By Nutrition Type (Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, and Others), By Formulation (Powder and Liquid), By Patient Type (Infant (1 month to 2 years), Children (2 to 12 years), Adolescent & Adult (12 to 65 years), Geriatric (>65 years), and Chronic Patient (Excluding all above in all age groups)), By Application (Cancer, Gastrointestinal Diseases, Diabetes, Critical Care, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-commerce), By End User (Hospitals, Home Care Settings, Retirement Homes, and Others), and By Region (North America, Latin America, Asia Pacific, and Europe, Middle East, and Africa), is estimated to be valued at US$ 2,635.9 million in 2020 and is expected to exhibit a CAGR of 5.8% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Enteral nutrition plays an important role in the management of certain chronic conditions such as diabetes, obesity, constipation, malabsorption, maldigestion, and others. It also helps to maintain healthy lifestyle, appetite and food intake, lowers the risk for nutrient deficiencies, and other health conditions.

Various manufacturers are engaged in development and launch of innovative and novel enteral nutrition products, which is expected to drive growth of the global enteral nutrition market.

For instance, in March 2020, Conagen Inc., a biotechnology company, announced that it developed a sustainable proprietary lactoferrin protein that mirrors the nutritional properties of lactoferrin from breast milk.

In February 2020, Danone, a food-products corporation, launched Aptamil baby formula pack with dual outer and inner QR codes for tracking and connecting services.

Furthermore, in July 2019, Nestle Inc. launched Modulen IBD, a new nutrition-based medical food product, for the management of Crohn's disease, which is administered through enteral route.

Global Enteral Nutrition Market – Impact of Coronavirus (Covid-19) Pandemic

Factors such as investments in research and development of novel nutritional products targeting COVID-19, as well as funding by various companies operating in the nutrition sector are expected to drive the enteral nutrition market growth.

For instance, in May 2020, Danone’s nutrition health arm, Nutricia, granted US$ 1.1 million for a global nutrition research program, a clinician-initiated research project in 16 countries across the world, to define guidelines for nutritional care for patients recovering from severe symptoms of COVID-19 and after discharge from intensive care unit (ICU).

In April 2020, Biosearch Life, a biotechnology company, launched a clinical trial examining the effect of its Hereditum Immunactiv K8 product on COVID-19. In March 2020, the company announced that its probiotic strain, Lactobacillus coryniformis CECT5711 K8, can reduce the virally transmitted respiratory infections in elderly populations.

Thus, the increasing availability of nutritional products to boost the immune system is expected to drive growth of the global enteral nutrition market during the pandemic.

Browse 287 Market Data Tables and 88 Figures spread through 636 Pages and in-depth TOC on “Global Enteral Nutrition Market”- Global Forecast to 2027, By Product Type (Standard Enteral Nutrition and Enteral Nutrition for Chronic Illness), By Nutrition Type (Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, and Others), By Formulation (Powder and Liquid), By Patient Type (Infant (1 month to 2 years), Children (2 to 12 years), Adolescent & Adult (12 to 65 years), Geriatric (>65 years), and Chronic Patient (Excluding all above in all age groups)), By Application (Cancer, Gastrointestinal Diseases, Diabetes, Critical Care, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-commerce), By End User (Hospitals, Home Care Settings, Retirement Homes, and Others), and By Region (North America, Latin America, Asia Pacific, and Europe, Middle East, and Africa).

To know the latest trends and insights prevalent in the global enteral nutrition market, click the link below:

https://www.coherentmarketinsights.com/market-insight/enteral-nutrition-market-1115

Key players in the global enteral nutrition market are focused on entering potential untapped markets in emerging economies such as India and China, where the prevalence of nutritional deficiency is high. For instance, according to data published by the Ministry of Health and Family Welfare (MoHFW), Government of India, in 2015, protein energy malnutrition (PEM) accounted for 60% of the total 10 million deaths of children younger than 5 years in India. Furthermore, there is a significant rise in healthcare expenditure and healthcare awareness in these economies, which is expected to facilitate the market growth in Asia Pacific region.

Key Takeaways of the Global Enteral Nutrition Market:

  • The global enteral nutrition market is expected to exhibit a CAGR of 5.8% over the forecast period, owing to increasing incidence of chronic diseases such as cancer, which is expected to drive the market growth over the forecast period. According to the European Commission reports in 2019, the estimated number of new cancer cases in 28 European countries was 1.6 million in males and 1.4 million in females.
  • Among product type, standard enteral nutrition segment is estimated to account for the largest market share in 2020, owing to launch of novel products. For instance, in June 2020, Otsuka Pharmaceutical Factory Inc. launched ENORAS Liquid for adult enteral use. ENORAS liquid is indicated for nutritional support in postoperative patients. It is specifically intended for tube feeding in patients in whom oral nutrition is inadequate.
  • Key players operating in the global enteral nutrition market include Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner